Dr. Bourla’s announcement was made via Twitter on the same day the FDA and CDC recommended the nation pause use of Johnson & Johnson’s COVID-19 vaccine. The FDA and CDC made the recommendation so they can review six reports of rare and serious blood clots in people who have received the shot.
Dr. Bourla said Pfizer has accelerated its COVID-19 vaccine production and will be able to fulfill the White House’s 300 million order two weeks before its due at the end of July.
More articles on pharmacy:
How Walgreens, CVS, states are handling the J&J vaccine pause
6 most reputable drugmakers
Biden: J&J pause won’t affect US vaccination pace
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
